The point is to calm any investor concern that they buy stock today and tomorrow he dilutes the pot. Dr. Missling is telling a group of financial experts that his company is financially stable. It's not bragging, it's material information that investors need to make informed decisions. Anavex has enough cash to last several years, it can easily afford to run another Alzheimer's trial, and it doesn't need to worry about taking on debt in these high-interest times we're living in.
If nothing else, Dr. Missling was smart to raise cash back when it was cheap to do so.
Market Data 
Markets 
AI
